Lead generation for biotech that reaches scientific buyers.
Biotech buyers are scientists first. They evaluate solutions through a lens of scientific rigour, regulatory compliance, and clinical evidence. We build campaigns that earn credibility with R&D leaders, regulatory affairs teams, and biotech investors.
Biotech is one of the most capital-intensive B2B markets, with sales cycles that can stretch 18 months or more. ORRJO builds outbound that reaches research directors, heads of procurement, and C-suite executives at pharma companies, CROs, and research institutions.
The Challenge
Scientific credibility is non-negotiable.
R&D leaders and regulatory professionals do not respond to marketing language. Your outreach needs to demonstrate genuine scientific understanding and reference real research or clinical context.
Regulatory constraints define everything.
FDA, EMA, and MHRA requirements shape every biotech purchase. Messaging that ignores regulatory context signals a vendor who does not understand the industry.
Long evaluation and validation cycles.
Biotech purchases can take 12-24 months. Validation, testing, and regulatory review add complexity that generic SaaS sales approaches cannot handle.
Our Approach
How ORRJO solves this.
We target biotech buyers by therapeutic area, development stage (discovery, preclinical, clinical), and the specific operational challenges they face: lab automation, data management, regulatory submissions, or manufacturing scale-up. Our research covers published clinical pipelines, FDA/EMA submissions, and partnership announcements.
Biotech buying decisions involve scientific, operational, and procurement stakeholders. Each evaluates your product through a completely different lens. The average B2B buying cycle is 10.1 months, but in biotech, procurement for lab equipment or software can take 12 to 24 months. Our multi-threaded campaigns maintain engagement across that entire timeline.
Scientific Buyer Targeting
We identify R&D Directors, VP Research, and regulatory affairs leaders at pharma, biotech, and CRO organisations.
Science-Grounded Messaging
Copy that references specific research applications, regulatory frameworks, and clinical contexts. Written with scientific accuracy.
Long-Cycle Nurture
Sustained campaigns designed for 12-24 month evaluation cycles. Consistent touchpoints that maintain engagement through validation processes.
Conference and Publication Campaigns
Outreach around major scientific conferences and tied to relevant publications.
What's Included
Outbound infrastructure for biotech vendors selling to pharma companies, CROs, CDMOs, and academic research institutions.
Scientific Buyer Data
Verified R&D and regulatory contacts at pharma, biotech, and CRO organisations.
Scientific Copy
Outreach grounded in real research applications and regulatory context.
Conference Campaigns
Event outreach around major scientific conferences.
Campaign Manager
A manager who understands biotech sales and scientific buyer psychology.
CRM Integration
Full pipeline tracking.
Performance Reporting
Weekly metrics and pipeline reports.
Results That Speak
LifeLink // Life Sciences Lead Generation
"ORRJO's outreach earned credibility with scientific buyers that other agencies could not match."
Founder, LifeLink
FAQ
Yes. Our copy references FDA, EMA, and MHRA requirements as appropriate. We work with your team to ensure scientific and regulatory accuracy.
Therapeutics, diagnostics, medical devices, CROs, CDMO, and biotech infrastructure (LIMS, ELN, data management).
Sustained nurture campaigns with regular touchpoints through 12-24 month evaluation cycles.
First meetings within 5-10 working days. Pipeline builds over 3-6 months.
Yes. Oncology, immunology, rare disease, neuroscience, and other therapeutic areas.
Monthly retainer. Book a strategy call.
Why ORRJO Is Different
Scientists do not respond to sales language.
Research scientists and biotech executives are among the most sceptical B2B buyers. They want peer-reviewed evidence, technical specifications, and validated performance data. Outbound that leads with business benefits over scientific credibility gets deleted immediately.
ORRJO's biotech campaigns lead with scientific substance. We reference the prospect's therapeutic focus, research challenges, and regulatory pathway. Our biotech clients report that prospects often request technical documentation during the first reply, a sign that the outreach earned enough credibility to start a real conversation.
Ready to reach biotech decision-makers?
Tell us about your ideal customer and we'll build the pipeline to reach them.
Book a Strategy Call →